Zevra Therapeutics, Inc. (ZVRA)
8.575
-0.20
(-2.33%)
USD |
NASDAQ |
Dec 09, 16:00
8.51
-0.06
(-0.76%)
After-Hours: 20:00
Zevra Therapeutics EPS Diluted (Quarterly): -0.0097 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Nektar Therapeutics | -1.875 |
| XOMA Royalty Corp. | 0.6991 |
| Akebia Therapeutics, Inc. | 0.002 |
| NovaBay Pharmaceuticals, Inc. | -0.22 |
| Palatin Technologies, Inc. | 4.258 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -0.544M |
| Revenue (Quarterly) | 26.06M |
| Total Expenses (Quarterly) | 26.61M |
| Enterprise Value | 357.50M |
| Gross Profit Margin (Quarterly) | 94.04% |
| Profit Margin (Quarterly) | -2.09% |
| Earnings Yield | 7.36% |
| Normalized Earnings Yield | 16.68 |